A first-of-its-kind study testing an mRNA vaccine for norovirus, the highly contagious winter vomiting bug, is launching in ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

A world-first vaccine for the vomiting bug norovirus is being trialled in the UK, with the hope it could cut the "burden" on ...

The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...

Dr Patrick Moore, the study's chief investigator and the National Institute for Health and Care Research (NIHR) director in ...

The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks, with results so far showing ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The FDA approves Pfizer's RSV vaccine, Abrysvo, for adults aged 18-59 years with increased risk of the disease.

There are currently no licenced norovirus vaccine anywhere in the world. CEO at the NIHR, Professor Lucy Chappell, added that ...

The winter vomiting bug affects millions of Britons every year, but a new vaccine could help reduce the massive impact of ...

Dr Patrick Moore, chief investigator of the study and National Institute for Health and Care Research (NIHR) director in the ...